BRIDGEBIO PHARMA, INC.

Lobbying for BRIDGEBIO PHARMA, INC. · Biotech company

Filing 1st Quarter - Amendment

1st Quarter (Jan 1 - Mar 31) 2024 · California · House · Senate · $160,000.00 expenses · posted Jul 17, 2026

Bills named in this filing 2

Lobbying activity 1

Pharmacy

Creating Hope Reauthorization Act of 2024 - H.R. 7384 Innovation in Pediatric Drugs Act - H.R. 6664 March-in/Bayh-Dole Act Orphan drug policies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.